Cephalon's 2% convertible notes, 0% convertibles are now convertible

By Devika Patel

Knoxville, Tenn., Feb. 12 - Cephalon, Inc.'s 2% convertible notes became convertible on Dec. 31, according to a 10-K filed Friday with the Securities and Exchange Commission.

The conversion opportunity arose because the closing price of the company's common stock on Dec. 31 was higher than the restricted conversion prices of the notes.

The company added that its 2010 zero-coupon notes are also convertible because their maturity is imminent.

Cephalon is a Frazer, Pa.-based biopharmaceutical company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.